Tracy Woody

Tracy Woody

Director/Board Member at
Shorla Pharma Ltd.

Net worth: 105 062 $ as of 31/05/2026

56 year
Health Technology
Consumer Services
Health Services

Profile

Tracy M.
Woody
is currently a Non-Executive Director at Shorla Pharma Ltd. since 2020.
Former positions include Chief Executive Officer at Retroject, Inc. from 2013 to 2015, Managing Director at Tmw Consulting, Inc. from 2013 to 2015, Independent Non-Executive Director at Esperion Therapeutics, Inc. from 2019 to 2026, Chief Commercial Officer at Zevra Therapeutics, Inc. from 2015 to 2016, Executive Vice President-Commercial Strategy at Protagonist Therapeutics, Inc. from 2020 to 2022, Chief Commercial Officer at Versartis, Inc. from 2017 to 2018, Chief Commercial Officer at Aravive, Inc. from 2017 to 2018, Director at ALZA Corp., Senior Manager-Marketing at Pfizer Inc., Vice President-Sales & Marketing at NextWave Pharmaceuticals, Inc., and Vice President-Business Development at Greer Laboratories, Inc. Education includes undergraduate studies at East Carolina University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/03/2026 33,566 ( 0.01% ) 105 062 $ 31/05/2026

Tracy Woody active positions

CompaniesPositionStart
Director/Board Member 10/11/2020

Former positions of Tracy Woody

CompaniesPositionEnd
ESPERION THERAPEUTICS, INC. Director/Board Member 28/05/2026
PROTAGONIST THERAPEUTICS, INC. Corporate Officer/Principal 01/09/2022
Corporate Officer/Principal 12/10/2018
ARAVIVE, INC. Corporate Officer/Principal 12/10/2018
ZEVRA THERAPEUTICS, INC. Corporate Officer/Principal 15/09/2016
See the detail of Tracy Woody's experience

Training of Tracy Woody

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

34

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!